Uni Eropa - Islandia - EMA (European Medicines Agency)

hra pharma rare diseases - mitotane - nýrnahettubólga - Æxlishemjandi lyf - einkenni meðferðar á háþróaðri (ómeðhöndluð, meinvörpum eða endurteknum) barkabólgu í nýrnahettum. Áhrif lysodren á virka ekki að mynda óeðlilega bylgja krabbamein er ekki stofnað.

Islandia - Islandia - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation (i)* - trimethoprimum inn - filmuhúðuð tafla - 160 mg

Islandia - Islandia - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris aps - trimethoprimum inn - mixtúra, dreifa - 10 mg/ml

Islandia - Islandia - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - linezolidum inn - innrennslislyf, lausn - 2 mg/ml

Islandia - Islandia - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation (i)* - trimethoprimum inn - filmuhúðuð tafla - 100 mg

Islandia - Islandia - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris aps - verapamilum hýdróklóríð - forðatafla - 120 mg

Uni Eropa - Islandia - EMA (European Medicines Agency)

provepharm sas - metýlþíóníumklóríð - methemóglóbíndreyri - Öll önnur lækningavörur - bráð einkenni meðhöndlunar á methemóglóbíndreyri í lyfjum og efnaafurðum. methylthioninium i proveblue er ætlað í fullorðnir, börn og unglingar (aldrinum 0 til 17 ára).

Uni Eropa - Islandia - EMA (European Medicines Agency)

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Uni Eropa - Islandia - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - Æxlishemjandi lyf - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

Islandia - Islandia - LYFJASTOFNUN (Icelandic Medicines Agency)

krka sverige ab - enalaprilum maleat; hydrochlorothiazidum inn - tafla - 20 mg /12,5 mg